Kimberly Lee | Chief Corporate Affairs Officer |
RA Session | President, Founder and Chief Executive Officer |
Suyash Prasad | Chief Medical Officer and Head of Research and Development |
Kamran Alam | Chief Financial Officer |
Fred Porter | Chief Technical Officer |
Gil Blum | Needham & Company, LLC |
Geulah Livshits | Chardan |
Mehdi Goudarzi | Truist Securities |
Michael Ulz | Morgan Stanley |
David Hoang | SMBC Nikko |
Benjamin Paluch | Robert W. Baird |
Yanan Zhu | Wells Fargo |
Tiffany Marchell | William Blair |
Whitney Ijem | Canaccord Genuity |
Thank you for standing by. Welcome to Taysha Gene Therapies Third Quarter 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in listen-only mode.
Following management's prepared remarks, we will hold a brief question-and-answer session.
As a reminder, this call is being recorded today, November 8, 2022.